1. Population pharmacokinetics and dosage optimization of linezolid in Chinese older patients.
- Author
-
Li, Yuanchen, Fang, Qiu, Wu, Zejun, Huang, Siqi, Ge, Weihong, Shen, Jizhong, and Zhu, Huaijun
- Subjects
- *
PHARMACEUTICAL arithmetic , *GOODNESS-of-fit tests , *RECEIVER operating characteristic curves , *RESEARCH funding , *RETROSPECTIVE studies , *DESCRIPTIVE statistics , *LONGITUDINAL method , *INTRAVENOUS therapy , *SIMULATION methods in education , *URIC acid , *LINEZOLID , *HOSPITAL care of older people , *PHARMACODYNAMICS - Abstract
Purpose: To assess the pharmacokinetics and pharmacodynamics of linezolid in a retrospective cohort of hospitalized Chinese older patients. Methods: Patients > 60 years of age, who received intravenous linezolid (600 mg), were included. A population pharmacokinetics (PPK) model was established using nonlinear mixed-effects modeling. The predictive performance of the final model was assessed using goodness-of-fit plots, bootstrap analyses, and visual predictive checks. Monte Carlo simulations were used to evaluate the achievement of a pharmacodynamics target for the area under the serum concentration–time curve/minimum inhibitory concentration (AUC0–24/MIC). Results: A total of 210 samples were collected from 120 patients. A one-compartment PPK model with linear elimination best predicted the linezolid plasma concentrations. Linezolid clearance (CL) was 4.22 L h−1 and volume of distribution (Vd) was 45.80 L; serum uric acid (SUA) was a significant covariate of CL. Conclusion: The results of this study indicated that the standard dose was associated with a risk of overexposure in older patients, particularly those with high SUA values; these patients would benefit from a lower dose (300 mg every 12 h). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF